PsyAccess
Comprobar elegibilidad
Comprobar elegibilidad
Spravato®Verificado en registro oficialModelo de centros designados

Altrecht

Utrecht, Países Bajos

Tratamiento y acceso

Sobre este proveedor

Los detalles a continuación están en inglés.

Altrecht offers esketamine nasal spray treatment for people with persistent (treatment-resistant) severe depression for whom multiple previous treatments had insufficient effect. After referral, an intake is planned to discuss the nature of the complaints and previous treatments; sometimes another treatment is advised before esketamine can be started. The treatment is delivered from outpatient clinic Focaal Utrecht at Nieuwe Houtenseweg 12 in the Lunetten area of Utrecht. After each administration patients are observed for 1.5 hours to monitor side effects such as dissociation and raised blood pressure. During the first four weeks patients come twice a week; the schedule thereafter depends on the observed effect. In about half of clients a clear reduction of depressive symptoms is seen after four weeks.

Servicios y programas

Los detalles a continuación están en inglés.

  • Esketamine nasal spray treatment for persistent (treatment-resistant) severe depression, delivered from outpatient clinic Focaal Utrecht

Preguntas frecuentes

Los detalles a continuación están en inglés.

Do I need a referral?

Yes. After referral an intake is planned to discuss your complaints and which previous treatments you have received. It is possible that another treatment is advised first before esketamine can be started.

What happens after each administration?

You must be observed for 1.5 hours to monitor side effects such as dissociation and raised blood pressure.

How often do I come for treatment?

During the first four weeks you come twice a week. After that the schedule depends on the effect that is seen.

What result can I expect?

In about half of clients a clear reduction of depressive complaints is seen after four weeks.

¿Considerando alternativas? Esketamine nasal spray treatment is offered by specialised centres across the Netherlands affiliated with the national Esketamine Nasal Spray Consortium (ENC-NL); for treatment-resistant depression it has been reimbursed from the basic health insurance package since September 2021.

Verificación

Este registro se tomó directamente de un registro oficial o una lista de programa y se revisa de nuevo con una cadencia continua.

¿Detectó un error? Vea nuestra metodología (en inglés) — allí se explica cómo se comprueban los registros y cómo notificar una corrección.